Waldinger Marcel D, Zwinderman Aeilko H, Olivier Berend
Department of Psychiatry and Neurosexology, Leyenburg Hospital, Leyweg 275, 2545 CH The Hague, The Netherlands.
Eur Urol. 2004 Oct;46(4):510-5; discussion 516. doi: 10.1016/j.eururo.2004.05.005.
To investigate the degree of ejaculation delay induced by on-demand treatment with 20 mg paroxetine and 25 mg clomipramine and to assess the type and severity of non-sexual side-effects of treatment at the day of and the day after treatment with these drugs.
A randomized, double-blind, fixed-dose, on-demand study in 30 men with lifelong premature ejaculation was performed. During a 1-month baseline period and a 4-week drug treatment period patients assessed the intravaginal ejaculation latency time (IELT) at home with a stopwatch. Only men with an IELT <1 min were randomly assigned to drug treatment. Patients assessed the drug coitus interval time (DCIT) and used the UKU side effect scale questionnaire at baseline, the day of and the day after intercourse.
On-demand treatment with 25 mg clomipramine, with a mean DCIT of 5.14 h, led to a 4.05 (95%CI: 3.26-5.02) fold-increase of the IELT. On-demand treatment with 20 mg paroxetine, with a mean DCIT of 5.39 h, led to a 1.41 (95%CI: 1.22-1.63) fold-increase of the IELT. Both drugs had a high incidence of non-sexual side effects at the coitus day and the next day. At the day of coitus paroxetine led to significant sleepiness and yawning compared to clomipramine. At the day after coitus clomipramine induced significant nausea compared to paroxetine.
On-demand treatment with 25 mg clomipramine led to a clinical relevant ejaculation delay. In contrast, 20 mg paroxetine had no clinical relevant ejaculation delay in men with lifelong premature ejaculation with an IELT of less than 1 minute. Both drugs exert mostly mild yet annoying non-sexual side effects both at the coitus day and the next day.
探讨按需服用20毫克帕罗西汀和25毫克氯米帕明引起射精延迟的程度,并评估服用这些药物当日及次日治疗的非性副作用的类型和严重程度。
对30名患有终身早泄的男性进行了一项随机、双盲、固定剂量、按需治疗的研究。在1个月的基线期和4周的药物治疗期内,患者在家中用秒表评估阴道内射精潜伏期(IELT)。只有IELT<1分钟的男性被随机分配接受药物治疗。患者在基线期、性交当日及次日评估药物性交间隔时间(DCIT),并使用UKU副作用量表问卷。
按需服用25毫克氯米帕明,平均DCIT为5.14小时,导致IELT增加4.05倍(95%CI:3.26 - 5.02)。按需服用20毫克帕罗西汀,平均DCIT为5.39小时,导致IELT增加1.41倍(95%CI:1.22 - 1.63)。两种药物在性交当日及次日非性副作用的发生率都很高。与氯米帕明相比,性交当日帕罗西汀导致明显的嗜睡和打哈欠。与帕罗西汀相比,性交次日氯米帕明引起明显的恶心。
按需服用25毫克氯米帕明导致临床相关的射精延迟。相比之下,20毫克帕罗西汀对IELT小于1分钟的终身早泄男性没有临床相关的射精延迟。两种药物在性交当日及次日大多产生轻微但恼人的非性副作用。